Long-term risk of primary liver cancers in entecavir versus tenofovir treatment for chronic hepatitis B

Long-term risk of primary liver cancers in entecavir versus tenofovir treatment for chronic hepatitis B

Abstract It remains controversial whether entecavir (ETV) and tenofovir disoproxil fumarate (TDF) is associated with different clinical outcomes for chronic hepatitis B (CHB). This study aimed to compare the long-term risk of ETV versus TDF on hepatocellular carcinoma (HCC) and intrahepatic cholangi...

Full description

Bibliographic Details
Main Authors: Te-Sheng Chang, Yao-Hsu Yang, Wei-Ming Chen, Chien-Heng Shen, Shui-Yi Tung, Chih-Wei Yen, Yung-Yu Hsieh, Chuan-Pin Lee, Meng-Ling Tsai, Chao-Hung Hung, Sheng-Nan Lu
Format: Article
Language:English
Published: Nature Publishing Group 2021-01-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-020-80523-7

Internet

https://doi.org/10.1038/s41598-020-80523-7

Similar Items